- Home
- LNTH vs BEP Comparison
LNTH vs BEP Comparison
Compare LNTH & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- BEP
- Stock Information
- Founded
- LNTH 1956
- BEP 1999
- Country
- LNTH United States
- BEP Canada
- Employees
- LNTH N/A
- BEP N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BEP Electric Utilities: Central
- Sector
- LNTH Health Care
- BEP Utilities
- Exchange
- LNTH Nasdaq
- BEP Nasdaq
- Market Cap
- LNTH 6.0B
- BEP 5.7B
- IPO Year
- LNTH 2015
- BEP N/A
- Fundamental
- Price
- LNTH $78.23
- BEP $23.43
- Analyst Decision
- LNTH Strong Buy
- BEP Buy
- Analyst Count
- LNTH 6
- BEP 6
- Target Price
- LNTH $132.67
- BEP $29.83
- AVG Volume (30 Days)
- LNTH 832.8K
- BEP 811.7K
- Earning Date
- LNTH 02-26-2025
- BEP 01-31-2025
- Dividend Yield
- LNTH N/A
- BEP 6.13%
- EPS Growth
- LNTH 304.57
- BEP N/A
- EPS
- LNTH 6.02
- BEP N/A
- Revenue
- LNTH $1,496,799,000.00
- BEP $5,876,000,000.00
- Revenue This Year
- LNTH $19.64
- BEP $4.22
- Revenue Next Year
- LNTH $5.16
- BEP $5.83
- P/E Ratio
- LNTH $12.99
- BEP N/A
- Revenue Growth
- LNTH 24.15
- BEP 16.63
- 52 Week Low
- LNTH $56.44
- BEP $19.92
- 52 Week High
- LNTH $126.89
- BEP $29.56
- Technical
- Relative Strength Index (RSI)
- LNTH 31.32
- BEP 61.80
- Support Level
- LNTH $79.39
- BEP $21.75
- Resistance Level
- LNTH $84.24
- BEP $23.13
- Average True Range (ATR)
- LNTH 3.84
- BEP 0.57
- MACD
- LNTH -0.93
- BEP 0.26
- Stochastic Oscillator
- LNTH 0.66
- BEP 89.53
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.